financetom
EDR
financetom
/
Communication Services
/
EDR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Endeavor Group Holdings, Inc.EDR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Endeavor Group Holdings, Inc. operates as an entertainment, sports, and content company worldwide.

The Owned Sports Properties segment operates a portfolio of sports properties, including Ultimate Fighting Championship, Professional Bull Rider, Euroleague, and Diamond Baseball Holdings that license broadcast and other intellectual property rights and operate exclusive live events.

The Events, Experiences & Rights segment provides services to live events, including sporting events, fashion, art fairs and music, culinary, and lifestyle festivals.

This segment also produces and distributes sports video programming, as well as operates events on behalf of third parties.

The Representation segment offers services to talent across entertainment, sports, and fashion, such as actors, directors, writers, athletes, models, musicians, and other artists in various mediums.

This segment provides brand strategy, marketing, advertising, public relations, analytics, digital, activation, and experiential services to corporate and other clients; intellectual property licensing services to a portfolio of entertainment, sports, and consumer product brands; and content development, production, financing, sales, and advisory services for television properties, documentaries, feature films, and podcasts.

The Sports Data & Technology segment delivers live streaming and data feeds for sports events to sportsbooks, rightsholders, and media partners, as well as on-demand virtual sports products and front-end solutions, including the UFC Event Centre.

This segment also specializes in betting engine products, services and technology, processing various bets annually, as well as trading, pricing, and risk management tools; player account and wallet solutions; front-end user experiences and user interfaces; and content offerings, such as BetBuilder, DonBest pricing feeds, and a sports content aggregation platform.

The company was founded in 1898 and is based in Beverly Hills, California.

Latest News >
BRIEF-Wiz Labors To Hire A CFO, Making An IPO Before 2026 Unlikely- The Information
BRIEF-Wiz Labors To Hire A CFO, Making An IPO Before 2026 Unlikely- The Information
Aug 14, 2024
Aug 14 (Reuters) - * WIZ LABORS TO HIRE A CFO, MAKING AN IPO BEFORE 2026 UNLIKELY- THE INFORMATION Source: https://tinyurl.com/3vt7kjm4 ...
European Wax Center Names David Berg CEO
European Wax Center Names David Berg CEO
Aug 14, 2024
09:20 AM EDT, 08/14/2024 (MT Newswires) -- European Wax Center ( EWCZ ) said Wednesday that the board named David Berg its chief executive, succeeding David Willis. The company said Berg, whose appointment took effect Monday, will also continue serving as its executive chairman. Berg previously served as the company's CEO from 2018 to 2023, European Wax Center ( EWCZ...
What 5 Analyst Ratings Have To Say About Cipher Mining
What 5 Analyst Ratings Have To Say About Cipher Mining
Aug 14, 2024
Throughout the last three months, 5 analysts have evaluated Cipher Mining ( CIFR ) , offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...
Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?
Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?
Aug 14, 2024
Wednesday, Viracta Therapeutics Inc. ( VIRX ) stock is trading higher after the company reported Phase 2 NAVAL-1 trial results from Stages 1 and 2 of the relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) cohort. Twenty-one patients with primarily Stage III-IV disease received nanatinostat in combination with valganciclovir. As of the June 28 data cutoff, combined...
Copyright 2023-2026 - www.financetom.com All Rights Reserved